12.35 - 13.05

Innovation session

Room 10b

Anti-TNF Failure in Psoriatic Arthritis - What Next?

Our expert faculty will be discussing the importance of early identification of treatment failure in patients with psoriatic arthritis. Through a variety of case studies, we will evaluate the potential treatment options for patients who have failed their first-line therapy, in order to prevent progression of joint damage.

Chair: Professor Dennis Mcgonagle, Professor Of Regenerative Medicine, Leeds Teaching Hospitals NHS Trust, Leeds

Professor Dennis Mcgonagle, Professor Of Regenerative Medicine, Leeds Teaching Hospitals NHS Trust, Leeds

Ruth Slack, Rheumatology Clinical Nurse Specialist, West Suffolk NHS Trust, Bury St Edmunds

This meeting is organised and supported by Janssen and is intended for Healthcare Professionals only.

15.05 - 15.35

Innovation session

Room 10b

When is Rheumatoid Arthritis Auto-inflammatory?

This session will explore the possibility of a spectrum of Rheumatoid Arthritis and Auto-inflammatory syndromes, and a disease specific classification. It will also consider the possibility of targeted therapy and implications on current treatments.

Professor Dennis Mcgonagle, Professor Of Regenerative Medicine, Chapel Allerton Hospital, Leeds

Dr Sinisa Savic, Consultant Immunologist, St James University Hospital, Leeds

18.00 - 19.00

Symposium

Room 9

The Evolving Biologic Landscape: Key considerations and decisions to integrate treatment options into clinical practice

The objectives of this interactive symposium are to: 

1. Evaluate the key considerations to optimise patient management in the evolving treatment landscape  

2. Consider the importance of setting and implementing quality standards to optimise service delivery and patient outcomes 

3. Discuss the practical decisions which need to be made to support the evolution of clinical practice

18.05: Key considerations with the evolving treatment landscape

Professor Peter Taylor, Norman Collisson Professor Of Musculoskeletal Sciences, University Of Oxford, Oxford

18.20: What standards should be set to optimise service delivery and patient outcomes?

Dr Zoe Cole, Consultant Rheumatologist, Salisbury District Hospital, Salisbury

18:35: Interactive discussion: Practical decisions to support the evolution of clinical practice

Professor Peter Taylor And Dr Zoe Cole

08.00 - 09.30

Symposium

Room 10b

iQ Communicator

Join us for clinical updates and UK-centric discussions with an expert panel.  Designed for UK healthcare professionals specialising in rheumatology, the iQ Communicator series brings the highlights of major international conferences to a UK audience, at a convenient place and before the ‘Hot Topics’ start to cool.

Chair: Prof Peter Taylor, Norman Collison Professor Of Musculoskeletal Sciences, Kennedy Institute Of Rheumatology, Oxford

08.00: Early Arthritis

Prof Peter Taylor, Norman Collison Professor Of Musculoskeletal Sciences, Kennedy Institute Of Rheumatology, Oxford

08.30: Axial SpA Update

Dr Raj Sengupta, Consultant Rheumatologist, The Royal National Hospital For Rheumatic Diseases, Bath

09.00: Comorbidities in Inflammatory Arthritis

Prof Chris Edwards, Consultant Rheumatologist, University Hospital Southampton Foundation Trust, Southampton

iQ Communicator is a symposium jointly convened by the BSR and Pfizer. The faculty were identified by the BSR and the programme Chair, and speakers have selected their own content for the meeting. Logistics and editorial support have been co-ordinated by Pfizer. The symposium is funded by Pfizer as part of its sponsorship of the BSR Autumn Conference.

10.50 - 11.20

Innovation session

Room 10b

The IL-17 pathway: a promising target to treat psoriatic arthritis.

Review of the available data specific to the therapeutic potential of new biological therapies targeting the IL-17 pathway, for the management of psoriatic arthritis.

12.15 - 12.45

Innovation session

Room 10b

Immunopathology beyond the cell membrane: what drives inflammation from within the cell?

The objective of the session is to explore the impact of intracellular signalling pathways on RA pathogenesis as well as to understand the role of intracellular signalling molecules in mediating inflammatory responses.  This session will consist of a brief presentation followed by a Q&A and facilitated discussion to encourage scientific exchange among experts in rheumatoid arthritis.

Chair: Dr Andrew Östör, Consultant Rheumatologist, Addenbrooke’s Hospital, Cambridge

Prof Peter Taylor, Norman Collisson Professor Of Musculoskeletal Sciences, Kennedy Institute Of Rheumatology, Oxford